Shenzhen Chipscreen Biosciences Co., Ltd. (688321) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenzhen Chipscreen Biosciences Co., Ltd.

Why is Shenzhen Chipscreen Biosciences Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Poor long term growth as Net Sales has grown by an annual rate of 30.34% and Operating profit at -271.37% over the last 5 years

With a growth in Operating Profit of 900.74%, the company declared Outstanding results in Mar 25

The company has declared positive results in Jan 70 after 2 consecutive negative quarters
OPERATING CASH FLOW(Y) Highest at CNY 72.98 MM
RAW MATERIAL COST(Y) Fallen by -2.2% (YoY)
NET PROFIT(9M) Higher at CNY -92.06 MM

With ROE of -2.90%, it has a risky valuation with a 8.88 Price to Book Value

Over the past year, while the stock has generated a return of 32.00%, its profits have risen by 60.4%

Market Beating Performance

The stock has generated a return of 32.00% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shenzhen Chipscreen Biosciences Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shenzhen Chipscreen Biosciences Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shenzhen Chipscreen Biosciences Co., Ltd.

36.68%

0.68

53.74%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

30.34%

EBIT Growth (5y)

-271.37%

EBIT to Interest (avg)

-4.81

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.58

Sales to Capital Employed (avg)

0.21

Tax Ratio

23.01%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

1.36%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

8.88

EV to EBIT

-159.08

EV to EBITDA

-807.85

EV to Capital Employed

6.58

EV to Sales

18.39

PEG Ratio

Dividend Yield

ROCE (Latest)

-4.14%

ROE (Latest)

-2.90%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 72.98 MM

RAW MATERIAL COST(Y)

Fallen by -2.2% (YoY

NET PROFIT(9M)

Higher at CNY -92.06 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 4.46%

NET SALES(Q)

At CNY 160.28 MM has Grown at 24.59%

-17What is not working for the Company

NET PROFIT(HY)

At CNY -82.71 MM has Grown at -118.89%

ROCE(HY)

Lowest at -7.1%

DEBT-EQUITY RATIO (HY)

Highest at 58.18 %

INTEREST(Q)

Highest at CNY 9.88 MM

Here's what is working for Shenzhen Chipscreen Biosciences Co., Ltd.

Operating Cash Flow

Highest at CNY 72.98 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 160.28 MM has Grown at 24.59%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debtors Turnover Ratio

Highest at 4.46%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -2.2% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenzhen Chipscreen Biosciences Co., Ltd.

Net Profit

At CNY -82.71 MM has Grown at -118.89%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 9.88 MM has Grown at 14.5%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at 58.18 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at CNY 9.88 MM

in the last five periods and Increased by 14.5% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)